These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7555207)

  • 21. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefonicid potentiation of human macrophage activity.
    Tullio V; Cuffini AM; Fazari S; Carlone NA
    Microbiologica; 1992 Jul; 15(3):219-26. PubMed ID: 1501583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophoretic mobility of cefodizime-treated Staphylococcus aureus and chemiluminescence of human polymorphonuclear leucocytes.
    Muratsugu M; Tomonaga M; Miyake Y; Terayama K; Ishida N
    J Antimicrob Chemother; 1991 Dec; 28(6):887-96. PubMed ID: 1816185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of subinhibitory concentrations of cumin (Cuminum cyminum L.) seed essential oil and alcoholic extract on the morphology, capsule expression and urease activity of Klebsiella pneumoniae.
    Derakhshan S; Sattari M; Bigdeli M
    Int J Antimicrob Agents; 2008 Nov; 32(5):432-6. PubMed ID: 18715764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
    Hostacká A
    Microbios; 1997; 91(368-369):137-43. PubMed ID: 9523422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice.
    Klesel N; Limbert M; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1984 Dec; 37(12):1712-8. PubMed ID: 6098572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular uptake and intraphagocytic activity of the new fluoroquinolone AF 3013 against Klebsiella pneumoniae.
    Tullio V; Cuffini AM; Bonino A; Ianni Palarchio A; Rossi V; Carlone NA
    Drugs Exp Clin Res; 1999; 25(1):1-11. PubMed ID: 10337499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulatory effect of cefodizime on macrophage-mediated phagocytosis.
    Oishi K; Matsumoto K; Yamamoto M; Morito T; Yoshida T
    J Antibiot (Tokyo); 1989 Jun; 42(6):989-92. PubMed ID: 2737956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of imipenem and meropenem on serum sensitivity and surface hydrophobicity of Klebsiella pneumoniae.
    Hostacká A
    Arzneimittelforschung; 1998 Nov; 48(11):1101-3. PubMed ID: 9850433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefodizime: effects of sub-inhibitory concentrations on adhesiveness and bacterial morphology of Staphylococcus aureus and Escherichia coli: comparison with cefotaxime and ceftriaxone.
    Braga PC; Dal Sasso M; Maci S
    J Antimicrob Chemother; 1997 Jan; 39(1):79-84. PubMed ID: 9044031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electron microscopic observation of the antibody-induced capsular swelling phenomenon in Klebsiella pneumoniae.
    Meno Y; Amako K
    Microbiol Immunol; 1996; 40(5):339-44. PubMed ID: 8999286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A nanomechanical study of the effects of colistin on the Klebsiella pneumoniae AJ218 capsule.
    Mularski A; Wilksch J; Hanssen E; Li J; Tomita T; Pidot SJ; Stinear T; Separovic F; Strugnell D
    Eur Biophys J; 2017 May; 46(4):351-361. PubMed ID: 27752727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Third generation oral cephalosporins: comparative in vitro kinetics.
    Speciale A; Blandino G; Nicoletti G
    J Chemother; 1995 May; 7 Suppl 1():9-12. PubMed ID: 8618112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of MICs and sub-MICs of antibiotics on production of capsular polysaccharide of Klebsiella pneumoniae.
    Held TK; Adamczik C; Trautmann M; Cross AS
    Antimicrob Agents Chemother; 1995 May; 39(5):1093-6. PubMed ID: 7625794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of subinhibitory concentrations of cephalosporins on surface properties and siderophore production in iron-depleted Klebsiella pneumoniae.
    Kadurugamuwa JL; Anwar H; Brown MR; Zak O
    Antimicrob Agents Chemother; 1985 Feb; 27(2):220-3. PubMed ID: 3157345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing.
    Allen PM; Fisher D; Saunders JR; Hart CA
    J Med Microbiol; 1987 Dec; 24(4):363-70. PubMed ID: 3320374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime.
    Fietta A; Bersani C; Bertoletti R; Grassi FM; Grassi GG
    Chemotherapy; 1988; 34(5):430-6. PubMed ID: 3053065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salicylate or bismuth salts enhance opsonophagocytosis of Klebsiella pneumoniae.
    Domenico P; Salo RJ; Straus DC; Hutson JC; Cunha BA
    Infection; 1992; 20(2):66-72. PubMed ID: 1582686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of surface hydrophobicity and charge of Staphylococcus aureus treated with sub-MIC of antibiotics and their effects on the chemiluminescence response of phagocytic cells.
    Nomura S; Kuroiwa A; Nagayama A
    Chemotherapy; 1995; 41(2):77-81. PubMed ID: 7758360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo morphological response of Klebsiella pneumoniae to cefotiam and cefazolin.
    Nakao M; Nishi T; Tsuchiya K
    Antimicrob Agents Chemother; 1981 May; 19(5):901-10. PubMed ID: 6271051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.